当前位置:首页 - 行情中心 - 科前生物(688526) - 财务分析 - 现金流量表

科前生物

(688526)

  

流通市值:68.33亿  总市值:68.33亿
流通股本:4.66亿   总股本:4.66亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金219,745,519.68904,601,039.08743,014,382.13476,305,454.78
  收到的税费返还--32,964.2632,964.26
  收到其他与经营活动有关的现金3,566,776.7441,495,964.4526,891,146.7611,996,849.97
  经营活动现金流入小计223,312,296.42946,097,003.53769,938,493.15488,335,269.01
  购买商品、接受劳务支付的现金14,918,179.2183,684,820.36151,831,907.9494,332,970.13
  支付给职工以及为职工支付的现金71,660,010.93195,371,574.78155,781,523.47114,623,639.19
  支付的各项税费47,518,647.0191,770,563.9871,557,689.0355,751,626.52
  支付其他与经营活动有关的现金38,743,895.97106,728,211.1975,053,245.1249,301,038.49
  经营活动现金流出小计172,840,733.12477,555,170.31454,224,365.56314,009,274.33
  经营活动产生的现金流量净额50,471,563.3468,541,833.22315,714,127.59174,325,994.68
二、投资活动产生的现金流量:
  收回投资收到的现金1,058,250,245.061,332,193,679.141,675,954,788.76594,435,398
  取得投资收益收到的现金13,615,479.2878,521,041.75110,440,942.5679,606,617.34
  处置固定资产、无形资产和其他长期资产收回的现金净额-7,754,731.68--
  投资活动现金流入小计1,071,865,724.341,418,469,452.571,786,395,731.32674,042,015.34
  购建固定资产、无形资产和其他长期资产支付的现金13,992,054.49123,878,027.0642,609,250.0731,261,572.46
  投资支付的现金1,085,990,0001,938,983,793.332,129,349,168.82575,299,930.56
  取得子公司及其他营业单位支付的现金-4,500,0004,500,0004,500,000
  支付其他与投资活动有关的现金--8,559,185.332,140,368.36
  投资活动现金流出小计1,099,982,054.492,067,361,820.392,185,017,604.22613,201,871.38
  投资活动产生的现金流量净额-28,116,330.15-648,892,367.82-398,621,872.960,840,143.96
三、筹资活动产生的现金流量:
  吸收投资收到的现金--17,692,58417,692,584
  取得借款收到的现金---0
  收到其他与筹资活动有关的现金-17,692,584--
  筹资活动现金流入平衡项目-000
  筹资活动现金流入小计-17,692,58417,692,58417,692,584
  分配股利、利润或偿付利息支付的现金-199,484,087.69199,543,845.81199,543,845.81
  支付其他与筹资活动有关的现金576,250.382,478,289.411,706,977.651,463,470.57
  筹资活动现金流出小计576,250.38201,962,377.1201,250,823.46201,007,316.38
  筹资活动产生的现金流量净额-576,250.38-184,269,793.1-183,558,239.46-183,314,732.38
四、汇率变动对现金及现金等价物的影响-9,243.55-2,056,879.58-47,468.47-505,291.59
五、现金及现金等价物净增加额21,769,739.22-366,677,207.28-266,513,453.2451,346,114.67
  加:期初现金及现金等价物余额176,801,385.46543,478,592.74543,478,592.74543,478,592.74
  期末现金及现金等价物余额198,571,124.68176,801,385.46276,965,139.5594,824,707.41
补充资料:
  净利润-416,941,266.13-219,277,761.2
  资产减值准备-12,636,565.86--671,363.37
  固定资产和投资性房地产折旧-107,523,702.65-53,534,989.63
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-107,523,702.65-53,534,989.63
  无形资产摊销-4,241,254.21-2,116,186.86
  长期待摊费用摊销-479,141.3-236,767.88
  处置固定资产、无形资产和其他长期资产的损失-6,896,508.3-0
  固定资产报废损失-508,769.61-144,434.38
  公允价值变动损失--33,271,389.35--13,267,119.68
  财务费用--44,499,804.47--24,882,373.92
  投资损失--7,405,727.22--3,572,559.49
  递延所得税-537,541.07-507,482.27
  其中:递延所得税资产减少-457,988.48-289,028
    递延所得税负债增加-79,552.59-218,454.27
  存货的减少--30,953,325.53--18,216,509.56
  经营性应收项目的减少-54,547,824.63-23,348,348.61
  经营性应付项目的增加--16,268,050.74--65,855,826.48
  其他-4,831,281.82--
  融资租入固定资产-895,040.65--
  现金的期末余额-176,801,385.46-594,824,707.41
  减:现金的期初余额-543,478,592.74-543,478,592.74
  现金及现金等价物的净增加额--366,677,207.28-51,346,114.67
公告日期2026-04-302026-04-082025-10-302025-08-26
审计意见(境内)标准无保留意见
TOP↑